ThermoGenesis Corp. INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • July 11th, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT is made as of the 7th day of July 2017, by and among ThermoGenesis Corp., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
THERMOGENESIS CORP. RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTRight of First Refusal and Co-Sale Agreement • July 11th, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • Delaware
THIS RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT is made as of the 7th day of July, 2017 by and among Thermogenesis Corp., a Delaware corporation (the “Company”), the Investors listed on Schedule A, and the Key Holders listed on Schedule B.
THERMOGENESIS CORP. VOTING AGREEMENTVoting Agreement • July 11th, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • Delaware
THIS VOTING AGREEMENT is made and entered into as of this 7th day of July, 2017 by and among ThermoGenesis Corp., a Delaware corporation (the “Company”), each holder of the Company’s Common Stock, $0.001 par value per share (“Common Stock”) listed on Schedule A (together with any subsequent investors, or transferees, who become parties hereto as “Stockholders” pursuant to Subsections 5.1(a) or 5.2 below, the “Stockholders”).
ASSET ACQUISITION AGREEMENT between SYNGEN INC. and THERMOGENESIS CORP. dated as of July 7, 2017Asset Acquisition Agreement • July 11th, 2017 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • Delaware
This Asset Acquisition Agreement (this “Agreement”), dated as of July 7, 2017 (the “Effective Date”), is entered into between SynGen Inc., a Delaware corporation (“Transferor”), and ThermoGenesis Corp., a Delaware corporation (“Acquiror”).
